Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Eps Bio Technology Corp. — Predicate Candidate Screening

24 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

95 daysmedian FDA review time
333 days90th percentile
24clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K201258EASYMAX Tag Self-Monitoring Blood Glucose SystemEps Bio Technology Corp.2021-09-014780
K190189MDT2 BLE Self-Monitoring Blood Glucose SystemEps Bio Technology Corp.2019-11-012730
K182057EasyMax BT Self-Monitoring Blood Glucose SystemEps Bio Technology Corp.2018-08-24240
K133537EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MEps Bio Technology Corp.2014-04-281610
K133389EM40 SELF-MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.2014-04-151610
K133647EMV3.1 PRO BLOOD GLUCOSE SYSTEM AND EMV3.1 SELF MONITORING BEps Bio Technology Corp.2014-02-27920
K121207EASYMAX MU SELF MONITORING BLOOD GLUCOSE SYSTEM, EASYMAX MU Eps Bio Technology Corp.2012-05-18280
K113243EM50 SELF MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.2012-03-281470
K112901EME SELF MONITORING BLOOD GLUCOSE SYSTEM, EME PRO SELF MONITEps Bio Technology Corp.2011-12-23810
K111728EMV3 SELF MONITORING BLOOD GLUCOSE SYSTEM, EMV3 PRO SELF MONEps Bio Technology Corp.2011-09-16880
K112272EM44 SELF MONITORING BLOOD GLUCOSE SYSTEM, EM44 PRO SELF MONEps Bio Technology Corp.2011-09-07300
K102345EASYMAX T1 SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL EPS10Eps Bio Technology Corp.2011-06-213060
K101037EG V1 (BL) SELF MONITORING GLUCOSE TEST SYSTEM MODEL: EPS100Eps Bio Technology Corp.2011-05-234040
K101457EASYPLUS MINI R9N SELF MONITORING BLOOD GLUCOSE SYSTEM MODELEps Bio Technology Corp.2010-07-01360
K092894EASYMAX V SELF MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.2010-02-241560
K092887EASYPLUS MINI MASTERDRIVER SELF MONITORING BLOOD GLUCOSE SYSEps Bio Technology Corp.2009-10-21300
K091481EASYPLUS MINI R13N SELF MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.2009-08-18910
K091229GLUCOMANAGER DATA MANAGEMENT SOFTWAREEps Bio Technology Corp.2009-07-31950
K081796EASYPLUS MINI R2N SELF MONITORING GLUCOSE TEST SYSTEMEps Bio Technology Corp.2009-01-232120
K083099EASYMAX N SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL: EPS08Eps Bio Technology Corp.2009-01-16881
K082121EASYMAX SELF MONITORING GLUCOSE TEST SYSTEM, MODEL # EPS0800Eps Bio Technology Corp.2008-09-17510
K070053EASYPLUS MINI SELF MONITORING GLUCOSE TEST SYSTEM, MODELS R1Eps Bio Technology Corp.2007-12-033330
K061992EASYPLUS SELF MONITORING GLUCOSE TEST SYSTEM, MODEL EPS04014Eps Bio Technology Corp.2006-09-19680
K043245EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.2005-04-291570

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda